English | Español
English | Español
  • Insurance
  • Marketing
  • Pharmaceuticals
  • Technology/Innovation
  • Regulatory
  • Community
Patient Daily | Apr 30, 2026

GLP-1 drugs promise wider health benefits, but experts urge caution on use

Patient Daily | Apr 30, 2026

Apixaban reduces complications, helps older adults spend more time at home after blood clots

Patient Daily | Apr 30, 2026

Researchers find single protein guides brain synapses and blood vessel stability

Patient Daily | Apr 30, 2026

Study finds longer breastfeeding linked to better cognition in Chinese adolescents after SES adjustment

Patient Daily | Apr 30, 2026

AAFA highlights community support during National Asthma and Allergy Awareness Month

Patient Daily | Apr 30, 2026

Northwestern Medicine opens Center for Advanced Endoscopy at Central DuPage Hospital

Patient Daily | Apr 30, 2026

Alliance for Consumers report details $29M in trial lawyer PAC spending, largely backing Democratic candidates

Patient Daily | Apr 30, 2026

Legal Reform Institute: Municipality litigation is being used to bypass legislatures and regulate industries through court settlements

Trending

+ Regulatory
Patient Daily | Apr 28, 2026

Archo Advocacy CEO Toresco on PBMs: 'PBMs profit from keeping prices high. Patients pay the spread'

+ Pharmaceuticals
Patient Daily | Apr 24, 2026

Washington Post Opinion Editor on 340B drug discounts: 'The program has become a profit-making venture for big businesses'

+ Regulatory
Patient Daily | Apr 29, 2026

USC Schaeffer Center's Sood on PBMs: 'If PBMs want to claim they save employers and patients billions, they should be willing to prove it'

+ Regulatory
Patient Daily | Apr 24, 2026

Steve Forbes on 340B program: Hospitals use it ‘to divert taxpayer-subsidized benefits for patients to unrelated interests’

  • 1
  • 2
  • 3
  • 4
  • …
  • »
  • Last »


Community
Insurance
Marketing
Pharmaceuticals
Regulatory
Technology/Innovation
About
Contact
© 2026 Patient Daily